Home › Funds › Tri Locum Partners LP › JNJ

Tri Locum Partners LP position in JNJ

JOHNSON & JOHNSON · Health Care

Tri Locum Partners LP reported holding 73,559 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$19.5M, representing 3.85% of its reported portfolio and ranking #10 among its reported holdings. Tri Locum Partners LP has disclosed JNJ holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)73.56K sh
Reported value held$19.47M
Portfolio Weight3.85%
First reportedQ3 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Tri Locum Partners LP's JNJ position evolved

Tri Locum Partners LP first disclosed a stake in JNJ in Q3 2025 at 302,831 shares (US$56.2M). The position peaked in Q4 2025 at 603,143 shares, worth US$124.8M. Across 5 filings, Tri Locum Partners LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 73,559 shares valued at US$19.5M — a reduction of -351,386 shares quarter over quarter.. Notable position changes include a 99% increase in Q4 2025 (shares rose 18% over the following quarter), a 31% trim in Q1 2026 (shares rose 4% over the following quarter), a 83% trim in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 302.83K $56.15M New
Q4 2025 603.14K $124.82M Add
Q1 2026 414.50K $101.32M Reduce
Q2 2026 424.94K $107.92M Add
Q3 2026 73.56K $19.47M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Tri Locum Partners LP held JNJ?

Tri Locum Partners LP has disclosed JNJ holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Tri Locum Partners LP's current position in JNJ?

As of Q3 2026, Tri Locum Partners LP holds 73.56K shares of JNJ (JOHNSON & JOHNSON), valued at $19.47M, representing 3.85% of its reported portfolio and ranking #10.

Has Tri Locum Partners LP been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Tri Locum Partners LP reduced its position in JNJ. The position peaked in Q4 2025 at 603.14K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.